Schedule 13G ownership disclosure
INVIVO THERAPEUTICS HOLDINGS CORP.
Security class unavailable · CUSIP: 46186M506
Event date: 2020-10-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001553350-20-000963
- Form type
- SC 13G
- Filer
- INVIVO THERAPEUTICS HOLDINGS CORP.
- CIK
- CIK 1292519
- Filed
- Nov 02, 2020
- Reporting period
- Oct 22, 2020
- Description
- Schedule 13G beneficial ownership